Eli Lilly Clears Its Prior Peak at $1,283.66, Setting a Fresh 52-Week High

As seen on the 24/7 Wall St. homepage on October 20, 2026.

LLY Eli Lilly
New 52-week high $1,283.66 +0.3% vs prior high · 2026-08-19
$1.3k$1k$765

Eli Lilly just cleared its August 19 peak with a $1,283.66 close, a new 52-week high for the $1.1 trillion drugmaker. The stock has climbed roughly 60% from last October's $803 level, and two months of chop are now resolved to the upside.

Continue ReadingShow less

Eli Lilly closed at $1,283.66 on October 20, clearing the August 19 peak that had capped the stock for two months. Sellers defending that level have been absorbed, and new buyers are in control.

From a low of roughly $803 last October, the stock has climbed about 60% to today's record close, making Eli Lilly one of the stronger performers among large-cap pharmaceutical names over that span.

The two months between the August high and today's close were a consolidation that resolved decisively to the upside. Tight ranges that break out cleanly on the high side signal accumulated demand rather than exhausted momentum.

At a market capitalization around $1.1 trillion, Eli Lilly now ranks among the most valuable companies in the world. A new 52-week high at that scale reflects conviction from large institutional investors and raises the stakes for upcoming catalysts that will confirm or challenge the new price level.

Sources

Mentioned: LLY

Related Market Updates

Biggest movers · On the open
Gainers
  • NOCNorthrop Grumman$538+5.4%
  • LLYEli Lilly$1,285.71+3.7%
  • BMYBristol-Myers Squibb$60.96+3.6%
  • MRKMerck &$148.5+3.4%
  • ARGXargenx$853.32+3.4%
Losers
  • IRENIREN$25.85-6.8%
  • CIFRCipher Digital$8.35-6.6%
  • LCIDLucid$2.91-6.1%
  • AAOIApplied Optoelectronics$73.51-6.0%
  • COHRCoherent$218.97-5.6%

Defense and big pharma own the top of the board at the open, led by Northrop Grumman up 5.36%, with Eli Lilly, Bristol-Myers Squibb and Merck also higher. The pain is concentrated in crypto miners and optics names, where IREN leads the decline.

Read more
Jim Cramer
PODCAST Mad Money w/ Jim Cramer Jim Cramer · 44 min

Mad Money w/ Jim Cramer 10/15/26

  • Diversification pitch: Korean memory selling in SK Hynix and Samsung is bleeding into US data center names
  • Schwab called a buy near $94, under 15x this year's earnings, after AI displacement fears knocked it from $114
  • Chevron preferred over Exxon on a swap; Home Depot held as the most rate-levered name he knows
  • Trim half of Oracle after the run; Microsoft left alone into earnings on Azure strength

Cramer is pulling money toward consumer staples, retailers and oils while the data center complex cracks, and he is framing Schwab's selloff on AI-agent worries as a repeat of the 2023 banking scare that proved a buying opportunity. For anyone concentrated in AI hardware, the Oracle half-sell is the clearest sell discipline he offered all episode.

Read more
LLY Eli Lilly
Regular session
$1214.81
+3.32% open $1175.72
$1.2k$1.2k$1.2k

A 3.32% intraday gain to $1,214.81 adds roughly $36 billion in market value, the kind of single-session swing a $1.1 trillion company rarely posts. Keep an eye on whether it holds into the close.

Read more
LLY Eli Lilly
Regular session
$1213.48
+3.21% open $1175.72

A 3.2% intraday move to $1,213.48 adds roughly $35 billion of market value to a trillion-dollar drugmaker in a single session. Moves that size are rare for a name this big, so keep an eye on whether it holds into the close.

Read more
LLY Eli Lilly
Regular session
$1135.59
-3.68% open $1179.02
$1.2k$1.2k$1.1k

A 3.7% slide to $1,135.59 shaves tens of billions off a trillion-dollar market cap in a single session, a rare swing for a megacap this size. Whether it holds above the open at $1,179.02 by the close is the thing to keep an eye on.

Read more
Read more